Loading...

LTRN LANTERN PHARMA INC Expansion Plans 8-K Filing

LNTR

LTRN

LANTERN PHARMA INC

(LTRN)

2026 8-K

AI Platform Demonstration

Financial Results Release

AI Tools Presentation

Financial Results Announcement

Annual Meeting Results

Financial Results Announcement

Equity Offerings

Financial Statements

Financial Results

Management Changes

Q3 Results Call

Q3 Earnings Announcement

Annual Meeting of Stockholders

By-laws Amendment

Earnings Reports

Earnings Reports

Management Changes

Investment Agreement

Death of Director

Earnings Reports

Annual Meeting of Stockholders

Earnings Reports

Earnings Reports

Salary Increase

External Links:

On April 9, 2026, Lantern Pharma Inc. showcased its AI platform, withZeta.ai, aimed at cancer drug discovery and clinical trial design during a live demonstration. The company discussed its commercial strategy and competitive positioning in the rare cancer market.

AI Assistant

LANTERN PHARMA INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.